Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney Transplant

Clinical trial NCT04665310 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04665310
Sponsor: The Methodist Hospital Research Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Kidney Disease, End-Stage Donor Specific Antibodies Acute Rejection of Renal Transplant

Start date: 2018-09-01
Primary completion: 2025-07-31
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.